The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles-Reference-Cited by-同舟云学术

The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles

Published:1983 Issue:3 Volume:1 Page:219-224
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neuro-Oncol

Author:

Feun Lynn G.,Savaraj Niramol,Lu Katherine,Guo Zhengang,Raulston L. Gilbert,Benjamin Robert S.,Fields William S.,Loo Ti Li

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00165606.pdf

Reference22 articles.

1. Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinone. J Med Chem 19:213?317, 1976.

2. Mellet LB: Physico-chemical consideration and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep 61:527?531, 1977.

3. Driscoll JS, Dudeck L, Congleton G, Geron RI: Potential CNS antitumor agents VI. J Pharm Sci 68:185?188, 1979.

4. Chou FL, Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinone. J Med Chem 19:1302?1308, 1976.

5. Driscoll JS: Aziridinylquinone antitumor agents.Chem Abstr 87:194?230, 1977.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism and reactions of quinoid anticancer agents;Pharmacology & Therapeutics;1987-01

2. Comparison of CNS Penetration, Tissue Distribution, and Pharmacology of VP 16–213 by Intracarotid and Intravenous Administration in Dogs;Cancer Investigation;1987-01

3. A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors;Journal of Neuro-Oncology;1984